Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Fujisawa withdraws NDA for vamicamide

Oct. 1, 1998

PSA is a useful indicator of prostate cancer in finasteride-treated patients

Sep. 21, 1998

Preliminary analysis indicates good efficacy and safety of resiniferatoxin in urge incontinence

Sep. 18, 1998

New bladder-selective M3 antagonist from Yamanouchi for urinary urge incontinence

Sep. 18, 1998

New treatment for BPH discovered by Hungarian research team

Sep. 17, 1998

Bioniche receives EU registration for Cystistat

Sep. 16, 1998

Adrenergic agents for BPH described by Abbott in patent literature

Sep. 15, 1998

New agent for unstable bladder introduced in U.K.

Sep. 11, 1998

WAY-140288: a follow-up V2 antagonist and aquaretic agent from Wyeth-Ayerst

Aug. 28, 1998

Profile of VPA-985, Wyeth-Ayerst's aquaretic agent in clinical trials

Aug. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...